about
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.Tumor metastasis to boneCD47 regulates bone mass and tumor metastasis to boneGranulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent mannerMetastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancerBone Metastasis from Renal Cell CarcinomaBone site-specific delivery of siRNAHypercalcemia of malignancy and new treatment optionsTargeting mast cells in gastric cancer with special reference to bone metastasesContemporary approaches for imaging skeletal metastasisBone metastases: When and how lung cancer interacts with boneBMPs and their clinical potentialsWhere Do Bone-Targeted Agents RANK in Breast Cancer Treatment?Targeting bone physiology for the treatment of metastatic prostate cancerSpinal metastasis in thyroid cancerTargeting tumor-stromal interactions in bone metastasisT cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancerCCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasisSmall-Molecule Inhibitors of the c-Fes Protein-Tyrosine KinaseBiology of bone metastases.Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancersThe insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialImplications of Hypoxia in Breast Cancer Metastasis to BoneRadium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case PresentationMechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone RemodelingJaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case reportKey roles of the OPG-RANK-RANKL system in bone oncologySynthesis and biological evaluation of a new polymeric conjugate and nanocarrier with osteotropic propertiesInflammation and skeletal metastasisA novel 3-D mineralized tumor model to study breast cancer bone metastasisDevelopment of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imagingReceptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsIdentification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTRadium-223 dichloride in clinical practice: a review.Halofuginone inhibits the establishment and progression of melanoma bone metastases.Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.Multiple myeloma presenting as spinal cord compression: a case report.Metastasis: a therapeutic target for cancer.
P2860
Q21142766-4F16E51A-5A8B-4CDE-AAEE-6C39D204DBB9Q21195416-92837537-92D7-472B-8A3A-3383D8F377FCQ24651925-1DE4BD0D-64AD-4094-82E4-D53D1B236890Q24683680-049516DF-9509-4DB2-B77E-51A11B532058Q24813688-CB845CC9-26B5-4C0F-A2CE-35A669D1E96FQ26746212-399E82DF-0649-4552-B658-6B38393D0190Q26747493-0AEFDD58-F763-442B-8E21-4C48AB09F28AQ26773973-C636CB35-2DA8-4DE7-BC9A-2EE8FF10E2FDQ26775300-B510C654-C42F-4CEC-9971-1B74FE23D306Q26784456-09FBB457-7647-4759-91DF-F7FFFA5CC2D1Q26798170-730AF15F-7E7F-4529-A2AB-7BC419C5FDFDQ26823287-C5704718-BDD1-4E57-A845-8B7FAB9654B7Q26824827-69F5C471-0461-4CF8-9BB8-CB9F2191A5ECQ26849473-DCE59162-F951-4CAC-93FE-422144EB4005Q26863249-E762826F-3F12-48B1-A649-A14A4DD03B37Q27003934-CC2A279D-5A9B-4CE1-A0B7-B94F53715CFFQ27024561-ED5BFF6F-C64C-4B0C-A9E6-B467E208FC4CQ27311542-2640A5EC-622F-4B57-8310-A9EFD3D8050BQ27348129-C44C630B-D946-4D03-A9C0-5FF3264B117AQ27437809-2FB73A8D-BE74-44EC-BA55-2671FCD16AF7Q27678635-AB8E94FA-9B7A-438B-AF0A-CBDD067FC251Q27693653-CEC3FB1A-B743-4762-B8B6-7BC42D436436Q27694500-108E8D48-BDD3-4DF6-B1B3-8277C690983FQ28075927-34F4D988-4626-4E9A-9702-C412557D3D0BQ28077444-0AF26712-6E77-43FA-8CF1-1A1ADA782F3AQ28077633-8ECFFBBA-71BD-4445-B170-58124CB96FF6Q28082335-832A040A-A847-4D5D-B021-C589DB00AA96Q28275303-A5FD1489-04EF-455E-BF7D-E3796C5F74A0Q28287394-A6831340-FAC8-48BB-874D-C075B433A166Q28386509-7C84C790-DA99-4938-BBB7-C55986870E8EQ28396089-B7CCDF49-0A6C-4CD4-AF8B-FDBF0285E28AQ28472598-5023A630-A03F-413F-8E7F-EB0CB534F44BQ28538391-811E56F1-3052-44FA-90BF-1B63DE10A51DQ28740575-B3543D3D-473C-444F-971D-399404AE448DQ28744173-C98A0254-0931-4ED4-9EC2-5391551CDFB9Q30251496-1EB14F46-9C70-477F-AEBB-D3C01202467BQ30393926-699FD8F0-0E37-4A08-9DAE-400D6A55EC90Q30417878-EB9CA2DC-66D9-4F05-88F1-084921F27667Q30435038-646F686F-AD8C-4B4C-9E14-2DE4B1A7A988Q30439221-A8DA9F58-728A-4AF7-A068-16899277D153
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Mechanisms of bone metastasis.
@ast
Mechanisms of bone metastasis.
@en
type
label
Mechanisms of bone metastasis.
@ast
Mechanisms of bone metastasis.
@en
prefLabel
Mechanisms of bone metastasis.
@ast
Mechanisms of bone metastasis.
@en
P356
P1476
Mechanisms of bone metastasis.
@en
P2093
G David Roodman
P304
P356
10.1056/NEJMRA030831
P407
P577
2004-04-01T00:00:00Z